Posttranfusion Cirrhosis, Non-A, Non-B Hepatitis, and the Acquired Immunodeficiency Syndrome
Authors: PAUL J. SCHMIDT
Journal: Annals of Internal Medicine (1987)

Letters and Corrections1 October 1987Posttranfusion Cirrhosis, Non-A, Non-B Hepatitis, and the Acquired Immunodeficiency SyndromePAUL J. SCHMIDT, M.D.PAUL J. SCHMIDT, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-107-4-597_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: All blood collected for transfusion in the United States is now tested to reduce the transmission of non-A, non-B hepatitis (1) by two tests on donor blood that relate statistically to the transmission of the disease. Tests for level of alanine aminotransferase and the presence of hepatitis B core antibody were recommended in 1984 and 1986 (2, 3). The test program (now called surrogate testing) causes the discard of 4% of the nation's blood supply after collection at a cost of about $65 million per year.The compelling argument that led to the decision to test was...References1. HOLLANDSCHMIDT PP, eds. Standards for Blood Banks and Transfusion Services. 12th ed. Arlington, Virginia: American Association of Blood Banks; 1987. Google Scholar2. STEVENSAACHHOLLINGER CRF. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. Ann Intern Med. 1984;101:733-8. LinkGoogle Scholar3. KOZIOLHOLLANDALLING DPD. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med. 1986;104:488-95. LinkGoogle Scholar4. ZUCKSHERWOODBOVE TWJ. A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis. Transfusion. 1987;27:203-6. CrossrefMedlineGoogle Scholar5. BOVERIGNEYKEHOECAMPBELL JPPJ. Look-back: preliminary experience of AABB members. Transfusion. 1987;27:201-2. CrossrefMedlineGoogle Scholar1. KOZIOLHOLLANDALLING DPD. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med. 1986;104:488-95. LinkGoogle Scholar2. DIENSTAGALTER JJ. Non-A, non-B hepatitis: evolving epidemiology and clinical perspective. Semin Liver Dis. 1986;6:67-81. CrossrefMedlineGoogle Scholar3. KIYOSAWAAKAHANENOGATA KYA. Significance of blood transfusion in non-A, non-B chronic liver diseases in Japan. Vox Sang. 1982;43:45-52. CrossrefMedlineGoogle Scholar4. ALTER M. NANB Hepatitis Epidemiology. In: Food and Drug Administration Workshop on Surrogate Testing for Non-A/Non-B Hepatitis. Rockville, Maryland: Food and Drug Administration; 1987:29. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Southwest Florida Blood Bank Tampa, FL 33601-2125 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDecision analysis in children with blunt splenic trauma: The effects of observation, splenorrhaphy, or splenectomy on quality-adjusted life expectancy 1 October 1987Volume 107, Issue 4Page: 597-598KeywordsAIDSAlanine aminotransferaseBlood banksBlood donorsBlood transfusionCirrhosisHematologic testsHepatitisHepatitis B Issue Published: 1 October 1987 PDF downloadLoading ...